Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.760
+0.040 (2.33%)
At close: Feb 6, 2026, 4:00 PM EST
1.780
+0.020 (1.14%)
After-hours: Feb 6, 2026, 7:54 PM EST
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $178.78 million as of February 6, 2026. Its market cap has increased by 31.66% in one year.
Market Cap
178.78M
Enterprise Value
153.41M
1-Year Change
31.66%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $178.78M, a decrease of -50.81%. That is a compound annual growth rate of -9.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 178.78M | -12.87% |
| Dec 31, 2025 | 205.20M | 31.26% |
| Dec 31, 2024 | 156.32M | 117.39% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crescent Biopharma | 183.96M |
| Minerva Neurosciences | 182.62M |
| Galectin Therapeutics | 182.46M |
| Surrozen | 182.14M |
| Sol-Gel Technologies | 180.24M |
| NeOnc Technologies Holdings | 179.94M |
| Opus Genetics | 177.93M |
| Sagimet Biosciences | 176.92M |